Vascular inflammation and the renin-angiotensin system

Atherosclerosis--an inflammatory disease

Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725 · see citing works

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663 · see citing works

Acute-Phase Proteins and Other Systemic Responses to Inflammation

Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · see citing works

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial

Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911 · see citing works

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · see citing works

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504 · see citing works

NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease

Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886 · see citing works

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.

Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735 · see citing works

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.

Rajagopalan, S., Kurz, S. D., Münzel, T. F., Tarpey, M. M., Freeman, B. Α., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,441 · see citing works

Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men

Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429 · see citing works

Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis

Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965 · see citing works

C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men

Köenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,952 · see citing works

Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells

Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,941 · see citing works

Molecular basis of human hypertension: Role of angiotensinogen

Jeunemaı̂tre, X., Soubrier, F., Kotelevtsev, Y. V., Lifton, R. P., Williams, C. S., Charru, A., Hunt, S. C., Hopkins, P. N., Williams, R. R., Lalouel, J.-M., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90275-h · Cited by 1,850 · see citing works

The CBP co-activator is a histone acetyltransferase

Bannister, A. J., & Kouzarides, T. (1996) · Nature · doi:10.1038/384641a0 · Cited by 1,824 · see citing works

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692 · see citing works

Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women

Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642 · see citing works

Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice

Gu, L., Okada, Y., Clinton, S. K., Gerard, C. J., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,574 · see citing works

Current Concepts of the Pathogenesis of the Acute Coronary Syndromes

Libby, P. (2001) · Circulation · doi:10.1161/01.cir.104.3.365 · Cited by 1,550 · see citing works

Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly

Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488 · see citing works

Cell transformation by the superoxide-generating oxidase Mox1

Suh, Y.-A., Arnold, R. S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A. B., Griendling, K. K., & Lambeth, J. D. (1999) · Nature · doi:10.1038/43459 · Cited by 1,480 · see citing works

STATs: Signal Transducers and Activators of Transcription

Ihle, J. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81277-5 · Cited by 1,381 · see citing works

Renin-angiotensin system: biochemistry and mechanisms of action.

Peach, M. J. (1977) · Physiological Reviews · doi:10.1152/physrev.1977.57.2.313 · Cited by 1,380 · see citing works

Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient mice

Daugherty, A., Manning, M. W., & Cassis, L. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7818 · Cited by 1,371 · see citing works

Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor

Murphy, T. J., Alexander, R. W., Griendling, K. K., Runge, M. S., & Bernstein, K. E. (1991) · Nature · doi:10.1038/351233a0 · Cited by 1,250 · see citing works

Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.

Rajagopalan, S., Meng, X. P., Ramasamy, S., Harrison, D. G., & Galis, Z. S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119076 · Cited by 1,137 · see citing works

Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study

Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,098 · see citing works

Cellular and molecular mechanisms of endothelial cell dysfunction.

Harrison, D. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119751 · Cited by 1,048 · see citing works

C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction

Ridker, P. M., Glynn, R. J., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.97.20.2007 · Cited by 1,012 · see citing works

Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases

Kim, S., & Iwao, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01434-0 · Cited by 985 · see citing works

Plasma Concentration of C-Reactive Protein and Risk of Developing Peripheral Vascular Disease

Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.97.5.425 · Cited by 973 · see citing works

The Renin-Angiotensin System

Reid, I. A., Morris, B. J., & Ganong, W. F. (1978) · Annual Review of Physiology · doi:10.1146/annurev.ph.40.030178.002113 · Cited by 957 · see citing works

Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology

Griendling, K. K., Sorescu, D., Lassegue, B. P., & Ushio‐Fukai, M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.10.2175 · Cited by 955 · see citing works

Human C-reactive protein: expression, structure, and function

Volanakis, J. E. (2001) · Molecular Immunology · doi:10.1016/s0161-5890(01)00042-6 · Cited by 928 · see citing works

C-Reactive Protein–Mediated Low Density Lipoprotein Uptake by Macrophages

Zwaka, T. P., Hombach, V., & Torzewski, J. (2001) · Circulation · doi:10.1161/01.cir.103.9.1194 · Cited by 845 · see citing works

Novel gp91 ^<i>phox</i> Homologues in Vascular Smooth Muscle Cells: nox1 Mediates Angiotensin II–Induced Superoxide Formation and Redox-Sensitive Signaling Pathways

Lassègue, B., Sorescu, D., Szöcs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S. L., Lambeth, J. D., & Griendling, K. K. (2001) · Circulation Research · doi:10.1161/hh0901.090299 · Cited by 839 · see citing works

Relationship of C-Reactive Protein to Risk of Cardiovascular Disease in the Elderly: Results From the Cardiovascular Health Study and the Rural Health Promotion Project

Tracy, R. P., Lemaitre, R. N., Psaty, B. M., Ives, D. G., Evans, R. W., Cushman, M., Meilahn, E. N., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1121 · Cited by 836 · see citing works

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.

Brand, K., Page, S., Rogler, G., Bartsch, A., Brandl, R., Knuechel, R., Page, M., Kaltschmidt, C., Baeuerle, P. A., & Neumeier, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118598 · Cited by 799 · see citing works

Tissue Angiotensin and Pathobiology of Vascular Disease

Dzau, V. J. (2001) · Hypertension · doi:10.1161/01.hyp.37.4.1047 · Cited by 748 · see citing works

NF-κB: pivotal mediator or innocent bystander in atherogenesis?

Collins, T., & Cybulsky, M. I. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10373 · Cited by 727 · see citing works

Association of the Renin-Sodium Profile with the Risk of Myocardial Infarction in Patients with Hypertension

Alderman, M. H., Madhavan, S., Ooi, W. L., Cohen, H. W., Sealey, J. E., & Laragh, J. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104183241605 · Cited by 726 · see citing works

Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis

Warnholtz, A., Nickenig, G., Schulz, E., Macharzina, R. R., Bräsen, J. H., Skatchkov, M. P., Heitzer, T. A., Stasch, J. P., Griendling, K. K., Harrison, D. G., et al. (1999) · Circulation · doi:10.1161/01.cir.99.15.2027 · Cited by 676 · see citing works

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

Yusuf, S., Pepine, C. J., Garces, C., Pouleur, H. G., Rousseau, M. F., Salem, D. N., Kostis, J. B., Benedict, C. R., Bourassa, M. G., & Pitt, B. (1992) · The Lancet · doi:10.1016/0140-6736(92)92889-n · Cited by 665 · see citing works

Expression of Angiotensin II and Interleukin 6 in Human Coronary Atherosclerotic Plaques

Schieffer, B., Schieffer, E., Hilfiker‐Kleiner, D., Hilfiker, A., Kovanen, P. T., Kaartinen, M., Nussberger, J., Harringer, W., & Drexler, H. (2000) · Circulation · doi:10.1161/01.cir.101.12.1372 · Cited by 654 · see citing works

Genetic control of blood pressure and the angiotensinogen locus.

Kim, H. S., Krege, J. H., Kluckman, K. D., Hagaman, J. R., Hodgin, J. B., Best, C. F., Jennette, J. C., Coffman, T. M., Maeda, N., & Smithies, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2735 · Cited by 640 · see citing works

Correction of Arterial Structure and Endothelial Dysfunction in Human Essential Hypertension by the Angiotensin Receptor Antagonist Losartan

Schiffrin, E. L., Park, J. B., Intengan, H. D., & Touyz, R. M. (2000) · Circulation · doi:10.1161/01.cir.101.14.1653 · Cited by 617 · see citing works

Circulating and tissue angiotensin systems.

Campbell, D. J. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112768 · Cited by 615 · see citing works

Linkage of the Angiotensinogen Gene to Essential Hypertension

Caulfield, M. J., Lavender, P., Farrall, M., Munroe, P. B., Lawson, M., Turner, P., & Clark, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302301 · Cited by 575 · see citing works

Reactive Oxygen Species Mediate the Activation of Akt/Protein Kinase B by Angiotensin II in Vascular Smooth Muscle Cells

Ushio‐Fukai, M., Alexander, R. W., Akers, M., Yin, Q., Fujio, Y., Walsh, K., & Griendling, K. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22699 · Cited by 558 · see citing works

Angiotensin II Stimulates Endothelial Vascular Cell Adhesion Molecule-1 via Nuclear Factor-κB Activation Induced by Intracellular Oxidative Stress

Pueyo, M. E., Gonzalez, W., Nicoletti, A., Savoie, F., Arnal, J., & Michel, J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.3.645 · Cited by 516 · see citing works

Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation

Massiéra, F., Bloch-Faure, M., Ceiler, D. L., Murakami, K., Fukamizu, A., Gasc, J., Quignard‐Boulangé, A., Négrel, R., Ailhaud, G. P., Seydoux, J., et al. (2001) · The FASEB Journal · doi:10.1096/fj.01-0457fje · Cited by 505 · see citing works

Endothelial Dysfunction: From Physiology to Therapy

Mombouli, J., & Vanhoutte, P. M. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0844 · Cited by 504 · see citing works

A molecular variant of angiotensinogen associated with preeclampsia

Ward, K., Hata, A., Jeunemaı̂tre, X., Helin, C., Nelson, L., Namikawa, C., Farrington, P., Ogasawara, M., Suzumori, K., TOMODA, S., et al. (1993) · Nature Genetics · doi:10.1038/ng0593-59 · Cited by 494 · see citing works

Angiotensin-Converting Enzyme Inhibition Prevents Arterial Nuclear Factor-κB Activation, Monocyte Chemoattractant Protein-1 Expression, and Macrophage Infiltration in a Rabbit Model of Early Accelerated Atherosclerosis

Hernández-Presa, M. Á., Bustos, C., Ortego, M., Tuñon, J., Renedo, G., Ruiz‐Ortega, M., & Egido, J. (1997) · Circulation · doi:10.1161/01.cir.95.6.1532 · Cited by 490 · see citing works

p47phox is required for atherosclerotic lesion progression in ApoE–/– mice

Barry-Lane, P. A., Patterson, C., van der Merwe, M., Hu, Z., Holland, S. M., Yeh, E. T. H., & Runge, M. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200111927 · Cited by 489 · see citing works

Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary Events

Biasucci, L. M., Liuzzo, G., Fantuzzi, G., Caligiuri, G., Rebuzzi, A. G., Ginnetti, F., Dinarello, C. A., & Maseri, A. (1999) · Circulation · doi:10.1161/01.cir.99.16.2079 · Cited by 484 · see citing works

The p300/CBP family: integrating signals with transcription factors and chromatin

Shiama, N. (1997) · Trends in Cell Biology · doi:10.1016/s0962-8924(97)01048-9 · Cited by 481 · see citing works

Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat.

Campbell, D. J., & Habener, J. F. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112566 · Cited by 481 · see citing works

Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle Cells

Kranzhöfer, R., Schmidt, J., Pfeiffer, C. A. H., Hagl, S., Libby, P., & Kübler, W. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.7.1623 · Cited by 480 · see citing works

Amyloid protein SAA is associated with high density lipoprotein from human serum.

Benditt, E. P., & Eriksen, N. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.4025 · Cited by 430 · see citing works

Increased Accumulation of Tissue ACE in Human Atherosclerotic Coronary Artery Disease

Diet, F., Pratt, R. E., Berry, G. J., Momose, N., Gibbons, G. H., & Dzau, V. J. (1996) · Circulation · doi:10.1161/01.cir.94.11.2756 · Cited by 425 · see citing works

Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.

Chobanian, A. V., Haudenschild, C. C., Nickerson, C., & Drago, R. (1990) · Hypertension · doi:10.1161/01.hyp.15.3.327 · Cited by 411 · see citing works

Angiotensin II Signaling in Vascular Smooth Muscle

Griendling, K. K., Ushio‐Fukai, M., Lassegue, B. P., & Alexander, R. W. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.366 · Cited by 406 · see citing works

Angiotensin II Induces Interleukin-6 Transcription in Vascular Smooth Muscle Cells Through Pleiotropic Activation of Nuclear Factor-κB Transcription Factors

Han, Y., Runge, M. S., & Brasier, A. R. (1999) · Circulation Research · doi:10.1161/01.res.84.6.695 · Cited by 377 · see citing works

Angiotensin II Induces Vascular Cell Adhesion Molecule-1 Expression In Rat Vasculature

Tummala, P. E., Chen, X., Sundell, C. L., Laursen, J. B., Hammes, C. P., Alexander, R. W., Harrison, D. G., & Medford, R. M. (1999) · Circulation · doi:10.1161/01.cir.100.11.1223 · Cited by 376 · see citing works

Angiotensin II–Induced Hypertension Accelerates the Development of Atherosclerosis in ApoE-Deficient Mice

Weiss, D., Kools, J. J., & Taylor, W. R. (2001) · Circulation · doi:10.1161/01.cir.103.3.448 · Cited by 368 · see citing works

C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men

Mendall, M. A. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1982 · Cited by 359 · see citing works

Infections, Inflammation, and the Risk of Coronary Heart Disease

Roivainen, M., Viik-Kajander, M., Palosuo, T., Toivanen, P., Leinonen, M., Saikku, P., Tenkanen, L., Manninen, V., Hovi, T., & Mänttäri, M. (2000) · Circulation · doi:10.1161/01.cir.101.3.252 · Cited by 347 · see citing works

Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators.

Rutherford, J. D., Pfeffer, M. A., Moyé, L. A., Davis, B. R., Flaker, G. C., Kowey, P. R., Lamas, G. A., Miller, H., Packer, M., & Rouleau, J. L. (1994) · Circulation · doi:10.1161/01.cir.90.4.1731 · Cited by 330 · see citing works

Stimulation of a Vascular Smooth Muscle Cell NAD(P)H Oxidase by Thrombin

Patterson, C., Ruef, J., Madamanchi, N. R., Barry-Lane, P., Hu, Z., Horaist, C., Ballinger, C. A., Brasier, A. R., Bode, C., & Runge, M. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19814 · Cited by 330 · see citing works

Essential Role of STAT3 in the Control of the Acute-Phase Response as Revealed by Inducible Gene Activation in the Liver

Alonzi, T., Maritano, D., Gorgoni, B., Rizzuto, G., Libert, C., & Poli, V. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1621-1632.2001 · Cited by 329 · see citing works

Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects.

Walker, W. G., Whelton, P. K., Saito, H., Russell, R. P., & Hermann, J. (1979) · Hypertension · doi:10.1161/01.hyp.1.3.287 · Cited by 292 · see citing works

Plasma clearance, organ distribution and target cells of interleukin‐6/hepatocyte‐stimulating factor in the rat

Castell, J. V., Geiger, T. M., Groß, V., Andus, T., WALTER, E., Hirano, T., Kishimoto, T., & Heinrich, P. C. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14383.x · Cited by 290 · see citing works

Role of NAD(P)H Oxidase in Angiotensin II–Induced JAK/STAT Signaling and Cytokine Induction

Schieffer, B., Luchtefeld, M., Braun, S., Hilfiker, A., Hilfiker‐Kleiner, D., & Drexler, H. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1195 · Cited by 273 · see citing works

Inhibition of Early Atherogenesis by Losartan in Monkeys With Diet-Induced Hypercholesterolemia

Strawn, W. B., Chappell, M. C., Dean, R. H., Kivlighn, S. D., & Ferrario, C. M. (2000) · Circulation · doi:10.1161/01.cir.101.13.1586 · Cited by 270 · see citing works

Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes

Fukamizu, A., Sugimura, K., Takimoto, E., Sugiyama, F., Seo, M. S., Takahashi, S., Hatae, T., Kajiwara, N., Yagami, K.-I., & Murakami, K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50246-0 · Cited by 268 · see citing works

Angiotensin II Induces LOX-1, the Human Endothelial Receptor for Oxidized Low-Density Lipoprotein

Morawietz, H., Rueckschloss, U., Niemann, B., Duerrschmidt, N., Galle, J., Hakim, K., Zerkowski, H., Sawamura, T., & Holtz, J. (1999) · Circulation · doi:10.1161/01.cir.100.9.899 · Cited by 254 · see citing works

Angiotensin II Stimulates Intercellular Adhesion Molecule-1 (ICAM-1) Expression by Human Vascular Endothelial Cells and Increases Soluble ICAM-1 Release In Vivo

Pastore, L., Tessitore, A., Martinotti, S., Toniato, E., Alesse, E., Bravi, M. C., Ferri, C., Desideri, G., Gulino, A., & Santucci, A. (1999) · Circulation · doi:10.1161/01.cir.100.15.1646 · Cited by 249 · see citing works

Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner

Ikeda, U., Ikeda, M., Oohara, T., Oguchi, A., Kamitani, T., Tsuruya, Y., & Kano, S. (1991) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1991.260.5.h1713 · Cited by 225 · see citing works

Genes coding for RNA polymerase β subunit in bacteria

Lisitsyn, N. A., MONASTYRSKAYA, G. S., & Sverdlov, E. D. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14384.x · Cited by 217 · see citing works

Mechanisms for Inducible Control of Angiotensinogen Gene Transcription

Brasier, A. R., & Li, J. (1996) · Hypertension · doi:10.1161/01.hyp.27.3.465 · Cited by 207 · see citing works

Elevated plasma interleukin-6 levels in patients with acute myocardial infarction

Miyao, Y., Yasue, H., Ogawa, H., Misumi, I., 増田, 武., Sakamoto, T., & Morita, E. (1993) · American Heart Journal · doi:10.1016/0002-8703(93)90526-f · Cited by 205 · see citing works

Acute and Chronic Angiotensin-1 Receptor Antagonism Reverses Endothelial Dysfunction in Atherosclerosis

Prasad, A., Tupas-Habib, T., Schenke, W. H., Mincemoyer, R., Panza, J. A., Waclawin, M. A., Ellahham, S. H., & Quyyumi, A. A. (2000) · Circulation · doi:10.1161/01.cir.101.20.2349 · Cited by 196 · see citing works

Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-κB (NF-κB) transcription factor

Brasier, A. R., Jamaluddin, M. F., Han, Y., Patterson, C., & Runge, M. S. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007133710837 · Cited by 181 · see citing works

Modulation of C-Reactive Protein-Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis Drugs

Pasceri, V., Chang, J., Willerson, J. T., & Yeh, E. T. H. (2001) · Circulation · doi:10.1161/01.cir.103.21.2531 · Cited by 181 · see citing works

Angiotensin II and atherosclerosis

Weiss, D., Sorescu, D., & Taylor, W. R. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01539-9 · Cited by 181 · see citing works

Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis

Navalkar, S., Parthasarathy, S., Santanam, N., & Khan, B. V. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01138-4 · Cited by 171 · see citing works

Angiotensin II and its receptors in the diabetic kidney

Burns, K. D. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.16192 · Cited by 156 · see citing works

Cellular Localization of Angiotensinogen Gene Expression in Brown Adipose Tissue and Mesentery: Quantification of Messenger Ribonucleic Acid Abundance Using Hybridization in Situ*

Campbell, D. J., & Habener, J. F. (1987) · Endocrinology · doi:10.1210/endo-121-5-1616 · Cited by 150 · see citing works

The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice

Hayek, T. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00239-4 · Cited by 146 · see citing works

Molecular Genetics of Human Hypertension: Role of Angiotensinogen

Corvol, P. L., & Jeunemaı̂tre, X. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.5.0312 · Cited by 145 · see citing works

Effects of Losartan on Angiotensin and Bradykinin Peptides and Angiotensin-Converting Enzyme

Campbell, D. J., Kladis, A., & Valentijn, A. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199508000-00009 · Cited by 145 · see citing works

Identification of NF-κB-Dependent Gene Networks in Respiratory Syncytial Virus-Infected Cells

Tian, B., Zhang, Y., Luxon, B. A., Garofalo, R. P., Casola, A., Sinha, M., & Brasier, A. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.13.6800-6814.2002 · Cited by 138 · see citing works

Multiple determinants for the high substrate specificity of an angiotensin II-forming chymase from the human heart.

Kinoshita, A., Urata, H., Bumpus, F. M., & Husain, A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54981-4 · Cited by 127 · see citing works

Platelet-Derived Interleukin-1 Induces Cytokine Production, but not Proliferation of Human Vascular Smooth Muscle Cells

Loppnow, H., Bil, R., Hirt, S. W., Schönbeck, U., Herzberg, M., Werdan, K., Rietschel, E. T., Brandt, E., & Flad, H. (1998) · Blood · doi:10.1182/blood.v91.1.134 · Cited by 122 · see citing works

Angiotensin II Generation at the Cell Surface of Activated Neutrophils: Novel Cathepsin G-Mediated Catalytic Activity That Is Resistant to Inhibition

Owen, C. A., & Campbell, E. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1436 · Cited by 118 · see citing works

Renin expression by vascular endothelial cells in culture.

Lilly, L. S., Pratt, R. E., Alexander, R. W., Larson, D. M., Ellison, K., Gimbrone, M. A., & Dzau, V. J. (1985) · Circulation Research · doi:10.1161/01.res.57.2.312 · Cited by 116 · see citing works

Angiotensinogen T235 expression is elevated in decidual spiral arteries.

Morgan, T. K., Craven, C., Nelson, L., Lalouel, J.-M., & Ward, K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119661 · Cited by 115 · see citing works

Angiotensin II Administration to Atherosclerotic Mice Increases Macrophage Uptake of Oxidized LDL

Keidar, S., Heinrich, R., Kaplan, M., Hayek, T., & Aviram, M. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0901.095547 · Cited by 113 · see citing works

Transcriptional Control Mechanism of Fibrinogen Gene Expression

Fuller, G. M., & Zhang, Z. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03534.x · Cited by 110 · see citing works

An inducible 50-kilodalton NF kappa B-like protein and a constitutive protein both bind the acute-phase response element of the angiotensinogen gene.

Ron, D., Brasier, A. R., Wright, K. A., Tate, J. E., & Habener, J. F. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.3.1023 · Cited by 107 · see citing works

Antiatherosclerotic and Antioxidative Effects of Captopril in Apolipoprotein E-Deficient Mice

Hayek, T., Attias, J., Smith, J. D., Breslow, J. L., & Keidar, S. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199804000-00011 · Cited by 107 · see citing works

Measurement of Plasma Renin Substrate by Radioimmunoassay of Angiotensin I: Concentration in Syndromes Associated with Steroid Excess

Krakoff, L. R. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-37-1-110 · Cited by 106 · see citing works

Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes.

Li, J., & Brasier, A. R. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.3.8833654 · Cited by 100 · see citing works

Angiotensin AT1 Receptor Antagonist Irbesartan Decreases Lesion Size, Chemokine Expression, and Macrophage Accumulation in Apolipoprotein E-Deficient Mice

Dol, F., Martin, G., Staels, B., Marés, A.-M., Cazaubon, C., Nisato, D., Bidouard, J., Janiak, P., Schaeffer, P., & Herbert, J. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200109000-00008 · Cited by 93 · see citing works

Reversing Endothelial Dysfunction With ACE Inhibitors

Rajagopalan, S., & Harrison, D. G. (1996) · Circulation · doi:10.1161/01.cir.94.3.240 · Cited by 86 · see citing works

Angiotensin-Converting Enzyme Inhibition Alters Nitric Oxide and Superoxide Release in Normotensive and Hypertensive Rats

Wiemer, G., Linz, W., Hatrik, S., Schölkens, B. A., & Maliñski, T. (1997) · Hypertension · doi:10.1161/01.hyp.30.5.1183 · Cited by 81 · see citing works

AT 1 Receptor Antagonism Reduces Endothelial Dysfunction and Intimal Thickening in Atherosclerotic Rabbits

Heras, N. D. L., Aragoncillo, P., Maeso, R., Vázquez-Pérez, S., Navarro‐Cid, J., deGasparo, M., Mann, J., Ruilope, L. M., Cachofeiro, V., & Lahera, V. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.969 · Cited by 77 · see citing works

Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells

Liang, J.-S., Schreiber, B. M., Salmona, M., Phillip, G., Gonnerman, W. A., de Beer, F. C., & Sipe, J. D. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37293-x · Cited by 75 · see citing works

Angiotensinogen Gene Expression Is Dependent on Signal Transducer and Activator of Transcription 3-Mediated p300/cAMP Response Element Binding Protein-Binding Protein Coactivator Recruitment and Histone Acetyltransferase Activity

Ray, S., Sherman, C. T., Lu, M., & Brasier, A. R. (2002) · Molecular Endocrinology · doi:10.1210/me.16.4.824 · Cited by 64 · see citing works

Angiotensin-Converting Enzyme Inhibitors and Insulin Sensitivity: Metabolic Effects in Hypertension, Diabetes, and Heart Failure

Donnelly, R. (1992) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199200111-00007 · Cited by 60 · see citing works

Acceleration of atherosclerotic lesions in transgenic mice with hypertension by the activated renin-angiotensin system.

Sugiyama, F., Haraoka, S., Watanabe, T., Shiota, N., Taniguchi, K., Ueno, Y., Tanimoto, K., Murakami, K., Fukamizu, A., & YAGAMI, K.-I. (1997) · PubMed · Cited by 60 · see citing works

ACE inhibition with perindopril and atherogenesis-induced structural and functional changes in minipig arteries.

Charpiot, P., Rolland, P. H., Friggi, A., Piquet, P., Scalbert, E., Bodard, H., Barlatier, A., Latrille, V., Tranier, P., & Mercier, C. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.8.1125 · Cited by 58 · see citing works

Potential indications for angiotensin-converting enzyme inhibitors in atherosclerotic vascular disease

Halkin, A., & Keren, G. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01001-4 · Cited by 54 · see citing works

Ramipril Prevents Endothelial Dysfunction Induced by Oxidized Low-Density Lipoproteins

Berkenboom, G. M., Langer, I., Carpentier, Y., Grosfils, K., & Fontaine, J. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.371 · Cited by 53 · see citing works

A comparison of the substrate specificities of cathepsin D and pseudorenin.

Dorer, F. E., Lentz, K. E., Kahn, J. R., Levine, M. A., & Skeggs, L. T. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40814-3 · Cited by 52 · see citing works

Role of Signal Transducers and Activators of Transcription 1 and -3 in Inducible Regulation of the Human Angiotensinogen Gene by Interleukin-6

Sherman, C. T., & Brasier, A. R. (2001) · Molecular Endocrinology · doi:10.1210/me.15.3.441 · Cited by 49 · see citing works

Proteolytic degradation of low density lipoproteins by arterial smooth muscle cells

Leake, D. S., & Peters, T. J. (1981) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(81)90033-3 · Cited by 40 · see citing works

Regulation of the angiotensin AT1 receptor expression by hypercholesterolemia.

Nickenig, G., & Böhm, M. (1997) · PubMed · Cited by 37 · see citing works

Chemistry of a human monocyte-derived cell line (U937): identification of the angiotensin I-converting activity as leukocyte cathepsin G

Snyder, R., Kaempfer, C. E., & Wintroub, B. (1985) · Blood · doi:10.1182/blood.v65.1.176.176 · Cited by 33 · see citing works

Angiotensinogen is an acute-phase protein in man

Nielsen, A. H., & Knudsen, F. (1987) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365518709168886 · Cited by 28 · see citing works

Transcription Factors NF‐IL6 and APRF Involved in gp130‐mediated Signaling Pathway a

Akira, S., Nishio, Y., Tanaka, T., Inoue, M., Matsusaka, T., Wang, X.-J., Wei, S., Yoshida, N., & Kishimoto, T. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb32310.x · Cited by 27 · see citing works

Effects of Quinapril and Losartan on Insulin Sensitivity in Genetic Hypertensive Rats with Different Metabolic Abnormalities

Nakagawa, H., Daihara, M., Tamakawa, H., Nozue, T., & Kawahara, K. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199907000-00005 · Cited by 24 · see citing works

Acute phase responses of plasma angiotensinogen and T-kininogen in rats

Okamoto, H., Hatta, A., Itoh, N., Ohashi, Y., Arakawa, K., & Nakanishi, S. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90225-5 · Cited by 23 · see citing works

Attenuation of Tissue P-Selectin and MCP-1 Expression and Intimal Proliferation by AT1 Receptor Blockade in Hyperlipidemic Rabbits

Chen, H. J., Li, D. Y., Saldeen, T. G. P., Phillips, M. I., & Mehta, J. L. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4590 · Cited by 20 · see citing works

The intracellular distribution of cathepsins and other acid hydrolases in mouse peritoneal macrophages.

Wiener, E., & Curelaru, Z. (1975) · PubMed · Cited by 11 · see citing works

IL-6 in inflammation, autoimmunity and cancer

Hirano, T. (2021) · International Immunology · doi:10.1093/intimm/dxaa078 · Cited by 1,453 · see citing works

Inflammatory cytokines in vascular dysfunction and vascular disease

Sprague, A. H., & Khalil, R. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.029 · Cited by 1,347 · see citing works

Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology

Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R. G., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,106 · see citing works

C-Reactive Protein and the Risk of Developing Hypertension

Sesso, H. D. (2003) · JAMA · doi:10.1001/jama.290.22.2945 · Cited by 1,005 · see citing works

Inflammation in Heart Failure

Murphy, S., Kakkar, R. K., McCarthy, C. P., & Januzzi, J. L. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.01.014 · Cited by 775 · see citing works

Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans

Vincent, H. K., & Taylor, A. G. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803177 · Cited by 738 · see citing works

Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins

Casserly, I., & Topol, E. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15900-x · Cited by 560 · see citing works

Inflammation in Hypertension

Xiao, L., & Harrison, D. G. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.01.013 · Cited by 551 · see citing works

The NF-κB Regulatory Network

Brasier, A. R. (2006) · Cardiovascular Toxicology · doi:10.1385/ct:6:2:111 · Cited by 528 · see citing works

ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome

Devaux, C. A., Rolain, J., & Raoult, D. (2020) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2020.04.015 · Cited by 477 · see citing works

Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity

Hansel, B., Giral, P., Nobécourt, E., Chantepie, S., Bruckert, É., Chapman, M. J., & Kontush, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0305 · Cited by 476 · see citing works

Interleukin-6 Induces Oxidative Stress and Endothelial Dysfunction by Overexpression of the Angiotensin II Type 1 Receptor

Waßmann, S., Stumpf, M., Strehlow, K., Schmid, A., Schieffer, B., Böhm, M., & Nickenig, G. (2003) · Circulation Research · doi:10.1161/01.res.0000115557.25127.8d · Cited by 469 · see citing works

An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice

Tieu, B. C., Lee, C., Sun, H., LeJeune, W. S., Recinos, A., Ju, X., Spratt, H. M., Guo, D., Milewicz, D. M., Tilton, R. G., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38308 · Cited by 463 · see citing works

Quantification of Isoprostanes as Indices of Oxidant Stress and the Risk of Atherosclerosis in Humans

Morrow, J. D. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000152605.64964.c0 · Cited by 452 · see citing works

Angiotensin receptors: a new role in cancer?

Deshayes, F., & Nahmias, C. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.07.009 · Cited by 437 · see citing works

Role of the renin–angiotensin system in vascular inflammation

Marchesi, C., Paradis, P., & Schiffrin, E. L. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.05.003 · Cited by 432 · see citing works

C-reactive protein and the risk of developing hypertension

Sesso, H. D., Buring, J. E., Rifai, N., Blake, G., Gaziano, J. M., & Ridker, R. M. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.02.025 · Cited by 431 · see citing works

Aortic Dissection Precedes Formation of Aneurysms and Atherosclerosis in Angiotensin II-Infused, Apolipoprotein E-Deficient Mice

Saraff, K., Babamusta, F., Cassis, L. A., & Daugherty, A. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000085631.76095.64 · Cited by 431 · see citing works

Inflammation in the genesis and perpetuation of atrial fibrillation

Engelmann, M. D. M., & Svendsen, J. H. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi350 · Cited by 419 · see citing works

JCS/JSCS 2020 Guideline on Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease

Fukazawa, R., Kobayashi, J., Ayusawa, M., Hamada, H., Miura, M., Mitani, Y., Tsuda, E., Nakajima, H., Matsuura, H., Ikeda, K., et al. (2020) · Circulation Journal · doi:10.1253/circj.cj-19-1094 · Cited by 415 · see citing works

Antiinflammatory Effects of Angiotensin II Subtype 1 Receptor Blockade in Hypertensive Patients With Microinflammation

Fliser, D., Buchholz, K., & Haller, H. G. (2004) · Circulation · doi:10.1161/01.cir.0000140265.21608.8e · Cited by 405 · see citing works

The metabolic syndrome: role of skeletal muscle metabolism.

Stump, C. S., Henriksen, E. J., Wei, Y., & Sowers, J. R. (2006) · Annals of Medicine · doi:10.1080/07853890600888413 · Cited by 362 · see citing works

Reduced Vascular Remodeling, Endothelial Dysfunction, and Oxidative Stress in Resistance Arteries of Angiotensin II–Infused Macrophage Colony-Stimulating Factor–Deficient Mice

Ciuceis, C. D., Amiri, F., Brassard, P., Endemann, D., Touyz, R. M., & Schiffrin, E. L. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000181743.28028.57 · Cited by 349 · see citing works

COVID-19 – A vascular disease

Siddiqi, H. K., Libby, P., & Ridker, P. M. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.10.005 · Cited by 340 · see citing works

Obesity and Thrombosis

Darvall, K., Sam, R. C., Silverman, S., Bradbury, A. W., & Adam, D. J. (2006) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2006.10.006 · Cited by 337 · see citing works

Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases

Vona, R., Gambardella, L., Cittadini, C., Straface, E., & Pietraforte, D. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8267234 · Cited by 338 · see citing works

Progenitor/stem cells give rise to liver cancer due to aberrant TGF-β and IL-6 signaling

Tang, Y., Kitisin, K., Jogunoori, W. S., Li, C., Deng, C., Mueller, S. C., Ressom, H. W., Rashid, A., He, A. R., Mendelson, J. S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705395105 · Cited by 312 · see citing works

Angiotensin II Induces Premature Senescence of Vascular Smooth Muscle Cells and Accelerates the Development of Atherosclerosis via a p21-Dependent Pathway

Kunieda, T., Minamino, T., Nishi, J.-I., Tateno, K., Oyama, T., Katsuno, T., Miyauchi, H., Orimo, M., Okada, S., Takamura, M., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.626606 · Cited by 302 · see citing works

Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification

Doherty, T. M., Fitzpatrick, L. A., Inoue, D., Qiao, J.-H., Fishbein, M. C., Detrano, R., Shah, P. K., & Rajavashisth, T. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0015 · Cited by 298 · see citing works

Roles of Oxidative Stress and Inflammation in Vascular Endothelial Dysfunction-Related Disease

Higashi, Y. (2022) · Antioxidants · doi:10.3390/antiox11101958 · Cited by 317 · see citing works

Systemic inflammation in heart failure – The whys and wherefores

Yndestad, A., Kristian Damås, J., Øie, E., Ueland, T., Gullestad, L., & Aukrust, P. (2006) · Heart Failure Reviews · doi:10.1007/s10741-006-9196-2 · Cited by 294 · see citing works

Associations between body mass index and the prevalence of low micronutrient levels among US adults.

Kimmons, J. E., Blanck, H. M., Tohill, B. C., Zhang, J., & Khan, L. K. (2006) · PubMed Central · Cited by 290 · see citing works

Inflammation in hypertension

Savoia, C., & Schiffrin, E. L. (2006) · Current Opinion in Internal Medicine · doi:10.1097/01.mnh.0000203189.57513.76 · Cited by 286 · see citing works

Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis

Kisseleva, T., & Brenner, D. A. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04658.x · Cited by 286 · see citing works

C‐Reactive Protein (CRP)‐Lowering Agents

Prasad, K. (2006) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2006.00033.x · Cited by 271 · see citing works

Novel Long Noncoding RNAs Are Regulated by Angiotensin II in Vascular Smooth Muscle Cells

Leung, A., Trac, C., Jin, W. L., Lanting, L. L., Akbany, A., Sætrom, P., Schones, D. E., & Natarajan, R. D. (2013) · Circulation Research · doi:10.1161/circresaha.112.300849 · Cited by 266 · see citing works

Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species

Wei, Y., Chen, K., Whaley‐Connell, A. T., Stump, C. S., Ibdah, J. A., & Sowers, J. R. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00561.2007 · Cited by 258 · see citing works

Postischemic Revascularization: From Cellular and Molecular Mechanisms to Clinical Applications

Silvestre, J., Smadja, D. M., & Levy, B. I. (2013) · Physiological Reviews · doi:10.1152/physrev.00006.2013 · Cited by 257 · see citing works

From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension

Schiffrin, E. L., & Touyz, R. M. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00262.2004 · Cited by 249 · see citing works

Redox‐dependent signalling by angiotensin II and vascular remodelling in hypertension

Touyz, R. M., Tabet, F., & Schiffrin, E. L. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03930.x · Cited by 236 · see citing works

Vascular Mechanobiology: Homeostasis, Adaptation, and Disease

Humphrey, J. D., & Schwartz, M. A. (2021) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-092419-060810 · Cited by 232 · see citing works

NFkappaB is a Key Player in the Crosstalk between Inflammation and Cardiovascular Diseases

Fiordelisi, A., Iaccarino, G., Morisco, C., Coscioni, E., & Sorriento, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071599 · Cited by 216 · see citing works

Ras Induces Vascular Smooth Muscle Cell Senescence and Inflammation in Human Atherosclerosis

Minamino, T., Yoshida, T., Tateno, K., Miyauchi, H., Zou, Y., Toko, H., & Komuro, I. (2003) · Circulation · doi:10.1161/01.cir.0000093274.82929.22 · Cited by 208 · see citing works

Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis—a randomized study

Takahashi, A., Takase, H., Toriyama, T., Sugiura, T., Kurita, Y., Ueda, R., & Dohi, Y. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl293 · Cited by 205 · see citing works

Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II – editorial review

Touyz, R. M. (2005) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200503000-00007 · Cited by 204 · see citing works

Oxidized Low-Density Lipoprotein and Atherosclerosis Implications in Antioxidant Therapy

Mitra, S., Deshmukh, A. J., Sachdeva, R., Lü, J., & Mehta, J. L. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318224a147 · Cited by 197 · see citing works

Curcumin as a natural regulator of monocyte chemoattractant protein-1

Karimian, M. S., Pirro, M., Majeed, M. A., & Sahebkar, A. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.10.001 · Cited by 196 · see citing works

Inflammation as a Regulator of the Renin-Angiotensin System and Blood Pressure

Satou, R., Penrose, H. M., & Navar, L. G. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0900-0 · Cited by 193 · see citing works

Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology

Eguchi, S., Kawai, T., Scalia, R., & Rizzo, V. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.10266 · Cited by 189 · see citing works

C-reactive protein and interleukin-6 in vascular disease

Rattazzi, M., Puato, M., Faggin, E., Bertipaglia, B., Zambon, A., & Pauletto, P. (2003) · Journal of Hypertension · doi:10.1097/00004872-200310000-00002 · Cited by 179 · see citing works

Multiple Biomarkers and the Risk of Incident Hypertension

Wang, T. J., Gona, P. N., Larson, M. G., Levy, D. A., Benjamin, E. J., Tofler, G. H., Jacques, P. F., Meigs, J. B., Rifai, N., Selhub, J., et al. (2007) · Hypertension · doi:10.1161/01.hyp.0000256956.61872.aa · Cited by 179 · see citing works

Role of inflammation in the progression of heart failure

Yndestad, A., Damås, J. K., Øie, E., Ueland, T., Gullestad, L. L., & Aukrust, P. (2007) · Current Cardiology Reports · doi:10.1007/bf02938356 · Cited by 177 · see citing works

Diastolic Dysfunction in Hypertensive Hearts: Roles of Perivascular Inflammation and Reactive Myocardial Fibrosis

Kai, H., Kuwahara, F., Tokuda, K., & Imaizumi, T. (2005) · Hypertension Research · doi:10.1291/hypres.28.483 · Cited by 174 · see citing works

A Review on Medicinal Properties of Orientin

Lam, K. Y., Ling, A. P. K., Koh, R. Y., Wong, Y. P., & Say, Y. (2016) · Advances in Pharmacological Sciences · doi:10.1155/2016/4104595 · Cited by 173 · see citing works

Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension

Navar, L. G., Prieto, M. C., Satou, R., & Kobori, H. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.01.009 · Cited by 169 · see citing works

The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction

Schmaier, A. H. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00535.2002 · Cited by 167 · see citing works

Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct–ligated rats†

Bataller, R. A., Gäbele, E., Parsons, C. J., Morris, T., Yang, L., Schoonhoven, R., Brenner, D. A., & Rippe, R. A. (2005) · Hepatology · doi:10.1002/hep.20665 · Cited by 166 · see citing works

Bone Marrow–Derived Monocyte Chemoattractant Protein-1 Receptor CCR2 Is Critical in Angiotensin II–Induced Acceleration of Atherosclerosis and Aneurysm Formation in Hypercholesterolemic Mice

Ishibashi, M., Egashira, K., Zhao, Q. D., Hiasa, K., Ohtani, K., Ihara, Y., Charo, I. F., Kura, S., Tsuzuki, T., Takeshita, A., et al. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000143384.69170.2d · Cited by 162 · see citing works

Inflammation in heart failure: pathophysiology and therapeutic strategies

Boulet, J., Sridhar, V. S., Bouabdallaoui, N., Tardif, J., & White, M. (2024) · Inflammation Research · doi:10.1007/s00011-023-01845-6 · Cited by 173 · see citing works

Psychological stress activates interleukin-1β gene expression in human mononuclear cells

Brydon, L., Edwards, S., Jia, H., Mohamed-Ali, V., Zachary, I., Martin, J. F., & Steptoe, A. (2005) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2004.12.003 · Cited by 159 · see citing works

Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study

Maruhashi, T., Soga, J., Fujimura, N., Idei, N., Mikami, S., Iwamoto, Y., Kajikawa, M., Matsumoto, T., Hidaka, T., Kihara, Y., et al. (2013) · Heart · doi:10.1136/heartjnl-2013-304739 · Cited by 159 · see citing works

Dietary carbohydrate intake is associated with cardiovascular disease risk in Korean: Analysis of the third Korea National Health and Nutrition Examination Survey (KNHANES III)

Park, S.-H., Lee, K.-S., & Park, H. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.10.011 · Cited by 157 · see citing works

Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: Therapeutic implications for cardiovascular diseases

Tousoulis, D., Andreou, I., Antoniades, C. A., Tentolouris, C. A., & Stefanadis, C. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.034 · Cited by 157 · see citing works

Renal and vascular hypertension-induced inflammation: role of angiotensin II

Ruiz‐Ortega, M., Esteban, V., Rupérez, M., Sánchez‐López, E., Rodríguez‐Vita, J., Carvajal, G., & Egido, J. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000203190.34643.d4 · Cited by 155 · see citing works

Effects of Angiotensin-Converting Enzyme Inhibitor Therapy on Clinical Outcome in Patients Undergoing Coronary Artery Bypass Grafting

Miceli, A., Capoun, R., Fino, C., Narayan, P., Bryan, A. J., Angelini, G. D., & Caputo, M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.008 · Cited by 155 · see citing works

Inflammation and Hypertension: The Interplay of Interleukin-6, Dietary Sodium, and the Renin-Angiotensin System in Humans

Chamarthi, B., Williams, G. H., Ricchiuti, V., Srikumar, N., Hopkins, P. N., Luther, J. M., Jeunemaı̂tre, X., & Thomas, A. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.113 · Cited by 154 · see citing works

Vascular cell senescence and vascular aging

Minamino, T., Miyauchi, H., Yoshida, T., Tateno, K., Kunieda, T., & Komuro, I. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.11.010 · Cited by 149 · see citing works

Roles of IL-6-gp130 Signaling in Vascular Inflammation

Hou, T., Tieu, B. C., Ray, S., Recinos, A., Cui, R., Tilton, R. G., & Brasier, A. R. (2008) · Current Cardiology Reviews · doi:10.2174/157340308785160570 · Cited by 149 · see citing works

Valsartan, Blood Pressure Reduction, and C-Reactive Protein

Ridker, P. M., Danielson, E., Rifai, N., & Glynn, R. J. (2006) · Hypertension · doi:10.1161/01.hyp.0000226046.58883.32 · Cited by 146 · see citing works

The role of angiotensin II in regulating vascular structural and functional changes in hypertension

Touyz, R. M. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0073-2 · Cited by 145 · see citing works

Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome

Skalický, J., Mužáková, V., Kanďár, R., Milan Meloun, A., Roušar, T., & Palička, V. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.096 · Cited by 142 · see citing works

Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver

Bataller, R. A., Gäbele, E., Schoonhoven, R., Morris, T., Lehnert, M., Yang, L., Brenner, D. A., & Rippe, R. A. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00037.2003 · Cited by 142 · see citing works

Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy

Jiang, Y.-Z., Rubin, L., Peng, T., Liu, L., Xing, X., Lazarovici, P., & Zheng, W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59272 · Cited by 141 · see citing works

Pro-inflammatory cytokines in acute coronary syndromes: From bench to bedside

Tousoulis, D., Antoniades, C., Koumallos, N., & Stefanadis, C. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.04.003 · Cited by 139 · see citing works

Role of the renin–angiotensin–aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction

Sciarretta, S., Paneni, F., Palano, F., Chin, D., Tocci, G., Rubattu, S., & Volpe, M. (2009) · Clinical Science · doi:10.1042/cs20080390 · Cited by 140 · see citing works

Inflammatory Responses Underlying the Microvascular Dysfunction Associated with Obesity and Insulin Resistance

Singer, G., & Granger, N. D. (2007) · Microcirculation · doi:10.1080/10739680701283158 · Cited by 138 · see citing works

Metabolic Syndrome as a Multifaceted Risk Factor for Oxidative Stress

Spahis, S., Borys, J.-M., & Levy, E. H. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6756 · Cited by 140 · see citing works

Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes: a literature review

von Frankenberg, A. D., Reis, A. F., & Gerchman, F. (2017) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000316 · Cited by 139 · see citing works

A Role of Matrix Metalloproteinase-8 in Atherosclerosis

Laxton, R. C., Hu, Y., Duchêne, J., Zhang, F., Zhang, Z., Leung, K., Xiao, Q., Scotland, R. S., Hodgkinson, C. P., Smith, K., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.200279 · Cited by 136 · see citing works

Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation

Zhang, G., LU, X., KIMURA, S., & Nishiyama, A. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.07.014 · Cited by 135 · see citing works

The attenuation of platelet and monocyte activation in a rabbit model of extracorporeal circulation by a nitric oxide releasing polymer

Major, T. C., Brant, D. O., Reynolds, M. M., Bartlett, R. H., Meyerhoff, M. E., Handa, H., & Annich, G. M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.12.028 · Cited by 134 · see citing works

Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib and Off-Target Toxicity

Vergeer, M., Bots, M. L., van Leuven, S. I., Basart, D. C. G., Sijbrands, E. J. G., Evans, G. W., Grobbee, D. E., Visseren, F. L. J., Stalenhoef, A. F. H., Stroes, E. S. G., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.772665 · Cited by 134 · see citing works

The Potential Influence of Inflammation and Insulin Resistance on the Pathogenesis and Treatment of Atherosclerosis-Related Complications in Type 2 Diabetes

Dandona, P., Aljada, A., Chaudhuri, A., & Bandyopadhyay, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030178 · Cited by 129 · see citing works

STAT3 NH2-Terminal Acetylation Is Activated by the Hepatic Acute-Phase Response and Required for IL-6 Induction of Angiotensinogen

Ray, S., Boldogh, I. R., & Brasier, A. R. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.07.055 · Cited by 129 · see citing works

Inflammation in venous thromboembolism: Cause or consequence?

Saghazadeh, A., Hafizi, S., & Rezaei, N. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.07.044 · Cited by 127 · see citing works

Effect of AT 1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-κB/IκB system

Sanz‐Rosa, D., Oubiña, M. P., Cediel, E., Heras, N. D. L., Vegazo, O., Jiménez, J., Lahera, V., & Cachofeiro, V. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01061.2003 · Cited by 125 · see citing works

Overexpression of SIRT1 in vascular smooth muscle cells attenuates angiotensin II-induced vascular remodeling and hypertension in mice

Gao, P., Xu, T., Lu, J., Li, L., Xu, J., Hao, D., Chen, H., & Liu, D. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1111-4 · Cited by 124 · see citing works

Angiotensin-Converting Enzyme Inhibitor Use Is Associated With Reduced Plasma Concentration of C-Reactive Protein in Patients With First-Ever Ischemic Stroke

Napoli, M. D., & Papa, F. (2003) · Stroke · doi:10.1161/01.str.0000099124.84425.bb · Cited by 123 · see citing works

Association of Leukocyte Telomere Length With Circulating Biomarkers of the Renin-Angiotensin-Aldosterone System

Vasan, R. S., Demissie, S., Kimura, M., Cupples, L. A., Rifai, N., White, C. C., Wang, T. J., Gardner, J. P., Cao, X., Benjamin, E. J., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.731794 · Cited by 121 · see citing works

Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice

Recinos, A., LeJeune, W. S., Sun, H., Lee, C. Y., Tieu, B. C., Lu, M., Hou, T., Boldogh, I. R., Tilton, R. G., & Brasier, A. R. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.10.013 · Cited by 120 · see citing works

Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats

Wei, Y., Clark, S. E., Morris, E. M., Thyfault, J. P., Uptergrove, G. M., Whaley‐Connell, A. T., Ferrario, C. M., Sowers, J. R., & Ibdah, J. A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.018 · Cited by 120 · see citing works

Pressure-Independent Effects of Angiotensin II on Hypertensive Myocardial Fibrosis

Tokuda, K., Kai, H., Kuwahara, F., Yasukawa, H., Tahara, N., Kudo, H., Takemiya, K., Koga, M., Yamamoto, T., & Imaizumi, T. (2003) · Hypertension · doi:10.1161/01.hyp.0000111831.50834.93 · Cited by 115 · see citing works

Adiponectin: an adipokine with protective features against metabolic syndrome.

Esfahani, M., Movahedian, A., Baranchi, M., & Goodarzi, M. T. (2015) · Europe PMC (PubMed Central) · Cited by 111 · see citing works

Models for the study of skin wound healing. The role of Nrf2 and NF-κB

Ambrožová, N., Jitka Ulrichová, A., & Galandáková, A. (2017) · Biomedical Papers · doi:10.5507/bp.2016.063 · Cited by 112 · see citing works

Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF

Yamagishi, S., Nakamura, K., Ueda, S., Kato, S., & Imaizumi, T. (2005) · Cell and Tissue Research · doi:10.1007/s00441-005-1094-8 · Cited by 111 · see citing works

The autoimmune origin of atherosclerosis

Blasi, C. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.025 · Cited by 108 · see citing works

Long noncoding RNA p21 enhances autophagy to alleviate endothelial progenitor cells damage and promote endothelial repair in hypertension through SESN2/AMPK/TSC2 pathway

Li, C., Lin, L., Zhang, L., Xu, R., Chen, X., Ji, J., & Li, Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105920 · Cited by 106 · see citing works

Regulation of angiotensin II actions by enhancers and super-enhancers in vascular smooth muscle cells

Das, S., Senapati, P., Chen, Z., Reddy, M. A., Ganguly, R., Lanting, L. L., Mandi, V., Bansal, A., Leung, A., Zhang, S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01629-7 · Cited by 103 · see citing works

The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA)

Lakoski, S. G., Cushman, M., Siscovick, D. S., Blumenthal, R. S., Palmas, W., Burke, G. L., & Herrington, D. M. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.91 · Cited by 105 · see citing works

NADPH Oxidase Contributes to Vascular Inflammation, Insulin Resistance, and Remodeling in the Transgenic (mRen2) Rat

Wei, Y., Whaley‐Connell, A. T., Chen, K., Habibi, J., Uptergrove, G. M., Clark, S. E., Stump, C. S., Ferrario, C. M., & Sowers, J. R. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.089284 · Cited by 105 · see citing works

Angiotensin II and vascular inflammation.

Cheng, Z. J., Vapaatalo, H., & Mervaala, E. M. A. (2005) · PubMed · Cited by 237 · see citing works

Role of the Renin-Angiotensin System in Vascular Diseases

Ruiz‐Ortega, M., Lorenzo, Ó., Rupérez, M., Esteban, V., Suzuki, Y., Mezzano, S. A., Plaza, J. J. G., & Egido, J. (2001) · Hypertension · doi:10.1161/hy1201.100589 · Cited by 309 · see citing works

Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle Cells

Kranzhöfer, R., Schmidt, J., Pfeiffer, C. A. H., Hagl, S., Libby, P., & Kübler, W. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.7.1623 · Cited by 480 · see citing works

Angiotensin II and atherosclerosis

Weiss, D., Sorescu, D., & Taylor, W. R. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01539-9 · Cited by 181 · see citing works

From endothelial dysfunction to vascular occlusion: role of the renin-angiotensin system.

Silva, P. M. (2010) · PubMed · Cited by 10 · see citing works